Signals of bleeding among direct-acting oral anticoagulant users compared to those among warfarin users: analyses of the post-marketing FDA Adverse Event Reporting System (FAERS) database, 2010–2015
Thamir M Alshammari,1–3 Sondus I Ata,4 Mansour Adam Mahmoud,5 Tariq M Alhawassi,2,4,6 Hisham S Aljadhey3 1Department of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia; 2Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia; 3Saudi Food...
Saved in:
Main Authors: | Alshammari TM (Author), Ata SI (Author), Mahmoud MA (Author), Alhawassi TM (Author), Aljadhey HS (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Heparin requirements for full anticoagulation are higher for patients on dabigatran than for those on warfarin – a model-based study
by: Edrich T, et al.
Published: (2015) -
Bleeding associated with self-medication in warfarin users: A prospective observational study in Ijuí (Brazil)
by: Christiane Colet, et al.
Published: (2023) -
Time to pregnancy recognition among users of an FDA-cleared fertility application
by: Agathe van Lamsweerde, et al.
Published: (2024) -
Pancreatitis with use of new diabetic medications: a real-world data study using the post-marketing FDA adverse event reporting system (FAERS) database
by: Khalidah A. Alenzi, et al.
Published: (2024) -
Pharmacovigilance of triazole antifungal agents: Analysis of the FDA adverse event reporting system (FAERS) database
by: Jianxing Zhou, et al.
Published: (2022)